Director William Teuber buys 3,000 IONQ shares at $38.38 as stock down 53.3% from 52-week high; stock now at $38.37.
Director William Teuber purchased 3,000 shares of IonQ at $38.38 on 2026-02-27, increasing his holdings by 46.8% to 9,413 shares total. The purchase occurred while the stock trades at $38.37, down 53.3% from its 52-week high of $82.09 and down 16.2% over the past 30 days. However, Teuber's prior open-market buy at this ticker on 2025-11-11 showed poor timing, declining 35.3% over the subsequent 90-day period, and his cross-ticker track record reflects an 0% win rate across 1 prior buy with an average 90-day return of -35.3%. IonQ remains unprofitable (net income $-1.1B in the latest full fiscal year), though it reported 201.8% annual revenue growth and quarterly revenue of $39.9M. The transaction's significance is modest given the director's historically unsuccessful market timing, the company's loss-making status, and the stock's ongoing price weakness despite the purchase.
IONQ director Teuber buys 2,000 shares at $54.82; stock now $45.40, down 41.5% in 30 days.
Director William J Teuber Jr purchased 2,000 shares at $54.82 on 2025-11-11, increasing his holdings from 4,413 to 6,413 shares—a 45.3% increase in his position. The purchase price sits well above the current market price of $45.40, and the stock has declined 41.5% over the preceding 30 days and is trading 44.7% below its 52-week high of $82.09. IONQ reported $39.9M in quarterly revenue with 95.4% annual revenue growth, but the company posted a net loss of $-1.1B in its most recent fiscal year and remains unprofitable. The insider's acquisition at a substantially higher price point than today's market, combined with the company's ongoing unprofitability despite strong revenue growth and recent sharp stock deterioration, creates a complex signal that merits scrutiny of both the transaction timing and the company's path to profitability.
